Probiotic supplementation decreases intestinal transit time: Meta-analysis of randomized controlled trials

World Journal of Gastroenterology

Volumn 19, Issue 29, 2013, Pages 4718-4725

  Miller, Larry E ^a   Ouwehand, Arthur C ^b  

^a Miller Scientific Consulting Inc   (United States)

^b DUPONT COMPANY   (United States)

Author keywords

Constipation; Gastrointestinal; Intestinal transit time; Meta analysis; Probiotics

Indexed keywords

PROBIOTIC AGENT;

ARTICLE; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM ANIMALIS HN019; CONSTIPATION; HUMAN; INTESTINE TRANSIT TIME; LACTOBACILLUS RHAMNOSUS; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC);

EID: 84881082594     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i29.4718     Document Type: Article

References (28)

1. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006; 130: 1377-1390. [PMID: 16678553 DOI: 10.1053/j.gastro.2006.03.008]
2. Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, Whitehead WE, Janssens J, Funch-Jensen P, Corazziari E. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993; 38: 1569-1580. [PMID: 8359066]
3. Ansari R, Sohrabi S, Ghanaie O, Amjadi H, Merat S, Vahedi H, Khatibian M. Comparison of colonic transit time between patients with constipation-predominant irritable bowel syndrome and functional constipation. Indian J Gastroenterol 2010; 29: 66-68. [PMID: 20443103 DOI: 10.1007/s12664-010-0015-2]
4. Tack J, Müller-Lissner S. Treatment of chronic constipation: current pharmacologic approaches and future directions. Clin Gastroenterol Hepatol 2009; 7: 502-508; quiz 496. [PMID: 19138759 DOI: 10.1016/j.cgh.2008.12.006]
5. Oelschlaeger TA. Mechanisms of probiotic actions - A review. Int J Med Microbiol 2010; 300: 57-62. [PMID: 19783474 DOI: 10.1016/j.ijmm.2009.08.005]
6. Malaguarnera G, Leggio F, Vacante M, Motta M, Giordano M, Bondi A, Basile F, Mastrojeni S, Mistretta A, Malaguarnera M, Toscano MA, Salmeri M. Probiotics in the gastrointestinal diseases of the elderly. J Nutr Health Aging 2012; 16: 402-410. [PMID: 22499466]
7. Girardin M, Seidman EG. Indications for the use of probiotics in gastrointestinal diseases. Dig Dis 2011; 29: 574-587. [PMID: 22179214 DOI: 10.1159/000332980]
8. European Food Safety Authority. Guidance on the scientific requirements for health claims related to gut and immune function. EFSA J 2011; 9: 1984 [DOI: 10.2903/j.efsa.2011.1984]
9. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 2009; 151: W65-W94. [PMID: 19622512 DOI: 10.7326/0003-4819-151-4-20 0908180-00136]
10. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12. [PMID: 8721797 DOI: 10.1016/0197-2456(95)00134-4]
11. Cohen J. Statistical power analysis for the behavioral sciences. Hillside, NJ: Lawrence Erlbaum Associates, 1987
12. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560. [PMID: 12958120 DOI: 10.1136/bmj.327.7414.557]
13. Egger M, Davey Smith G, Schneider M, Minder C. Bias in metaanalysis detected by a simple, graphical test. BMJ 1997; 315: 629-634. [PMID: 9310563]
14. Agrawal A, Houghton LA, Morris J, Reilly B, Guyonnet D, Goupil Feuillerat N, Schlumberger A, Jakob S, Whorwell PJ. Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation. Aliment Pharmacol Ther 2009; 29: 104-114. [PMID: 18801055 DOI: 10.1111/j.1365-2036.2008.03853.x]
15. Bartram HP, Scheppach W, Gerlach S, Ruckdeschel G, Kelber E, Kasper H. Does yogurt enriched with Bifidobacterium longum affect colonic microbiology and fecal metabolites in health subjects? Am J Clin Nutr 1994; 59: 428-432. [PMID: 8310997]
16. Bouvier M, Meance S, Bouley C, Berta J, Grimaud J. Effects of consumption of a milk fermented by the probiotic strain Bifidobacterium animalis DN-173 010 on colonic transit time in healthy humans. Bioscience Microflora 2001; 20: 43-48
17. Holma R, Hongisto SM, Saxelin M, Korpela R. Constipation is relieved more by rye bread than wheat bread or laxatives without increased adverse gastrointestinal effects. J Nutr 2010; 140: 534-541. [PMID: 20089780 DOI: 10.3945/ jn.109.118570]
18. Hongisto SM, Paajanen L, Saxelin M, Korpela R. A combination of fibre-rich rye bread and yoghurt containing Lactobacillus GG improves bowel function in women with self-reported constipation. Eur J Clin Nutr 2006; 60: 319-324. [PMID: 16251881]
19. Malpeli A, González S, Vicentin D, Apás A, González HF. Randomised, double-blind and placebo-controlled study of the effect of a synbiotic dairy product on orocecal transit time in healthy adult women. Nutr Hosp 2012; 27: 1314-1319. [PMID: 23165580]
20. Marteau P, Cuillerier E, Meance S, Gerhardt MF, Myara A, Bouvier M, Bouley C, Tondu F, Bommelaer G, Grimaud JC. Bifidobacterium animalis strain DN-173 010 shortens the colonic transit time in healthy women: a double-blind, randomized, controlled study. Aliment Pharmacol Ther 2002; 16: 587-593. [PMID: 11876714]
21. Rosenfeldt V, Paerregaard A, Nexmann Larsen C, Moller PL, Tvede M, Sandstrom B, Jakobsen M, Michaelsen KF. Faecal recovery, mucosal adhesion, gastrointestinal effects and tolerance of mixed cultures of potential prebiotic lactobacilli. Microbial Ecology in Health and Disease 2003; 15: 2-9
22. Sairanen U, Piirainen L, Gråsten S, Tompuri T, Mättö J, Saarela M, Korpela R. The effect of probiotic fermented milk and inulin on the functions and microecology of the intestine. J Dairy Res 2007; 74: 367-373. [PMID: 17692137]
23. Waller PA, Gopal PK, Leyer GJ, Ouwehand AC, Reifer C, Stewart ME, Miller LE. Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults. Scand J Gastroenterol 2011; 46: 1057-1064. [PMID: 21663486 DOI: 10.3109/00365521.2011.584895]
24. Krammer HJ, Seggem HV, Schaumburg J, Neumer F. Effect of Lactobacillus casei Shirota on colonic transit time in patients with chronic constipation. Coloproctology 2011; 33: 109-113
25. Saad RJ, Rao SS, Koch KL, Kuo B, Parkman HP, McCallum RW, Sitrin MD, Wilding GE, Semler JR, Chey WD. Do stool form and frequency correlate with whole-gut and colonic transit? Results from a multicenter study in constipated individuals and healthy controls. Am J Gastroenterol 2010; 105: 403-411. [PMID: 19888202 DOI: 10.1038/ajg.2009.612.]
26. Törnblom H, Van Oudenhove L, Sadik R, Abrahamsson H, Tack J, Simrén M. Colonic transit time and IBS symptoms: what's the link? Am J Gastroenterol 2012; 107: 754-760. [PMID: 22334251 DOI: 10.1038/ajg.2012.5]
27. Williams NT. Probiotics. Am J Health Syst Pharm 2010; 67: 449-458. [PMID: 20208051 DOI: 10.2146/ajhp090168]
28. Chmielewska A, Szajewska H. Systematic review of randomised controlled trials: probiotics for functional constipation. World J Gastroenterol 2010; 16: 69-75. [PMID: 20039451]